2017 Executive Sponsors
2017 Associate Sponsors
2017 Supporting Sponsor
2017 Supporting Partner
2017 Media Partners
2017 Supporting Partner
Eureka is a digital research platform, sponsored by the NIH, designed to facilitate mobile and internet-based medical or health-related research for any interested investigator. The Eureka platform is available to anyone who wants to conduct medical or health-related research, including NIH investigators, university or other non-profit investigators, industry investigators or others. The Eureka platform is designed for mobile research broadly defined as any research utilizing mobile applications (apps), sensors, connected devices, and/ or the Internet, or for investigators seeking to leverage technology to enhance the efficiency of human subject-based research. The Eureka platform includes an engaging participant-facing “front-end,” a study management portal, a secure “back-end” for data storage and analyses, and a cohort of volunteers interested in contributing to research. Learn more at http://info.eurekaplatform.org.
2017 Media Partners
Big3Bio provides coverage of the developments about and within the life science industry’s “Big 3” regions: Boston, the San Francisco Bay Area and San Diego. Our mission is to fulfill stakeholders’ needs for invaluable industry information by researching thousands of sources every day and sharing that coverage with our subscribers each morning via our free daily regional newsletters – Big3Bio:Boston, Big3Bio:SFBay and Big3Bio:San Diego.
Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.
BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousands of healthcare data points, aggregated into one centralized source. In addition to the proprietary articles, BioPharm Insight is currently tracking 500,000 management and R&D contacts, 7,500 biopharma companies with full pipeline data, 120,000 investigational and approved drug profiles, 28,000 M&A and licensing deals, 10,000 extended sales forecasts and epidemiology profiles for hundreds of indications. To learn more, visit www.biopharminsight.com and follow us on Twitter @BioPharmInsight
CanBiotech is an open innovation and patient engagement platform for the biotech and pharmaceutical industries. Visit CanBiotech to learn more about best practices for collaboration with industry stakeholders and patients. Participate in the discussion, attend upcoming events and training opportunities provided by CanBiotech and our partners in the areas of innovation program development, open bio-innovation, design thinking for health and patient engagement. For more information, visit www.canbiotech.com.
Since 1994, CenterWatch, has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from top sponsors and CROs to research sites and niche providers, as well as an engaged population of patients interested in clinical research and volunteering. Visit www.centerwatch.com to learn more about our industry-leading news publications, market research and data library, training resources, patient enrollment support, drug intelligence resources and more.
Life Science Leader magazine, a product of the Life Science Connect Media Group, strives to be an essential business tool for life science executives. As such, our content is designed to not only inform readers of industry best practices, but to motivate them to implement those best practices in their own businesses.
Each month, Life Science Leader features interviews of executives from the leading pharm and biotech companies, including Merck, Daiichi Sankyo, Genentech, Biogen Idec, Allergan, Pfizer, MedImmune, Genzyme, Eli Lilly, Janssen, the FDA, and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharmaceutical and biopharmaceutical markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes. Our monthly columns include “Companies to Watch,” “Capital Perspectives,” “Outsourcing Reports,” “Leadership Lessons,” and “Industry Insights.”
Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc. Learn more at www.pharmalicensing.com.
PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Visit www.pharmavoice.com
The Rebar Interactive blog is the official blog of Rebar Interactive, a digital strategy company specializing in patient engagement and recruitment for clinical trials. Articles provide unique insights not only on digital strategy and the patient experience, but also on general clinical trial innovation and technology topics. The primary author is Rahlyn Gossen, the founder of Rebar Interactive and a former clinical research coordinator, though various clinical trial experts are invited to guest blog on occasion. For more information, visit www.rebarinteractive.com
SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals – Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications – online. For more details regarding SciDoc Publishers, visit www.scidoc.org
Technology Networks is an internationally recognized publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas. Visit www.technologynetworks.com
We enjoy collaborating with the media. If you are interested in becoming a media partner, please contact:
Kim@tcfllc.org | 646-290-8449